{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:05Z","timestamp":1761059345827},"reference-count":105,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1173,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1742-1241.2012.02956.x","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T07:32:51Z","timestamp":1339745571000},"page":"622-630","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["New directions in cardiovascular risk assessment: the role of secondary risk stratification markers"],"prefix":"10.1155","volume":"66","author":[{"given":"A. S.","family":"Wierzbicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2010.09.002","article-title":"ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2012.02956.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)","volume":"14","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"Suppl. V","key":"10.1111\/j.1742-1241.2012.02956.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/hrt.2005.079988","article-title":"JBS 2: the Joint British Societies\u2019 guidelines for prevention of cardiovascular disease in clinical practice","volume":"91","author":"British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association","year":"2005","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB4|cit4","volume-title":"Lipid Modification","author":"National Institute for Health and Clinical Excellence","year":"2008"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ehj.2003.11.012","article-title":"Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease","volume":"25","author":"Emberson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/eurheartj\/ehl391","article-title":"Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study","volume":"28","author":"Penning-van Beest","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1525-1497.2003.30107.x","article-title":"Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians","volume":"18","author":"Sheridan","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/hrt.2010.214858","article-title":"Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose","volume":"97","author":"Tunstall-Pedoe","year":"2011","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-2362.2007.01888.x","article-title":"Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study","volume":"37","author":"Assmann","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"b2584","DOI":"10.1136\/bmj.b2584","article-title":"An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study","volume":"339","author":"Collins","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"b2673","DOI":"10.1136\/bmj.b2673","article-title":"QRISK or Framingham for predicting cardiovascular risk?","volume":"339","author":"Jackson","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"e18742","DOI":"10.1371\/journal.pone.0018742","article-title":"Screening for future cardiovascular disease using age alone compared with multiple risk factors and age","volume":"6","author":"Wald","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0195-668X(03)00471-8","article-title":"Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias","volume":"24","author":"Emberson","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00043798-200208000-00002","article-title":"Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes","volume":"9","author":"Reynolds","year":"2002","journal-title":"J Cardiovasc Risk"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"c6624","DOI":"10.1136\/bmj.c6624","article-title":"Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database","volume":"341","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50\u2003years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2006.09.099","article-title":"Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry)","volume":"99","author":"Lloyd-Jones","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/CIRCULATIONAHA.108.800235","article-title":"Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis","volume":"119","author":"Berry","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/heartjnl-2011-300747","article-title":"Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review","volume":"98","author":"Peters","year":"2012","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1742-1241.2008.01794.x","article-title":"Surrogate markers, atherosclerosis and cardiovascular disease prevention","volume":"62","author":"Wierzbicki","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-151-7-200910060-00010","article-title":"Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force","volume":"151","author":"Helfand","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","article-title":"Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","article-title":"Risk prediction models: II. External validation, model updating, and impact assessment","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/j.1742-1241.2010.02469.x","article-title":"Methods for evaluating novel biomarkers - a new paradigm","volume":"64","author":"Cook","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/HJR.0b013e3283347059","article-title":"Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics","volume":"17","author":"Romanens","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOL.0b013e32834c6245","article-title":"Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?","volume":"22","author":"de","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bimj.201000078","article-title":"Performance of reclassification statistics in comparing risk prediction models","volume":"53","author":"Cook","year":"2011","journal-title":"Biom J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1742-1241.2012.02908.x","article-title":"A review of family history of cardiovascular disease: risk factor and research tool","volume":"66","author":"Bannerjee","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-140-6-200403160-00010","article-title":"Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study","volume":"140","author":"Murabito","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/hrt.2006.108167","article-title":"Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)","volume":"93","author":"Woodward","year":"2007","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCULATIONAHA.107.688739","article-title":"Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"116","author":"Nasir","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"a1095","DOI":"10.1136\/bmj.a1095","article-title":"Familial hypercholesterolaemia: summary of NICE guidance","volume":"337","author":"Wierzbicki","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/157016108783331268","article-title":"Familial combined hyperlipidaemia: under - defined and under - diagnosed?","volume":"6","author":"Wierzbicki","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/eurheartj\/ehq038","article-title":"Genetics of myocardial infarction: a progress report","volume":"31","author":"Schunkert","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D\u2019Agostino","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/hrt.2006.087932","article-title":"Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review","volume":"92","author":"Brindle","year":"2006","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.jacc.2009.07.047","article-title":"Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study)","volume":"54","author":"Sacco","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1373\/clinchem.2008.122093","article-title":"Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US","volume":"55","author":"Cushman","year":"2009","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/hrt.2006.092346","article-title":"Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups","volume":"92","author":"Brindle","year":"2006","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1464-5491.2010.02921.x","article-title":"Do the Joint British Society (JBS2) guidelines on prevention of cardiovascular disease with respect to plasma glucose improve risk stratification in the general population? Prospective cohort study","volume":"27","author":"Brunner","year":"2010","journal-title":"Diabet Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc08-1918","article-title":"Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the","volume":"32","author":"Simmons","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/HCO.0b013e32832ac21a","article-title":"Lipoprotein a: where are we now?","volume":"24","author":"Tziomalos","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.294.14.1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1373\/clinchem.2008.115899","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers","year":"2009","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/eurheartj\/ehr262","article-title":"Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"33","author":"Sever","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"e19852","DOI":"10.1371\/journal.pone.0019852","article-title":"Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA\/KORA Augsburg case-cohort study","volume":"6","author":"Herder","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study","volume":"1","author":"Wilson","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacc.2011.02.041","article-title":"N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease","volume":"58","author":"Wannamethee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"51F","DOI":"10.1016\/j.amjcard.2008.04.019","article-title":"Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines","volume":"101","author":"Davidson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/01.CIR.0000143377.53389.C8","article-title":"Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany","volume":"110","author":"Koenig","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2796.2010.02258.x","article-title":"Lipoprotein-associated phospholipase A activity and mass in relation to vascular disease and nonvascular mortality","volume":"268","author":"Heart Protection Study Group","year":"2010","journal-title":"J Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jacc.2006.08.052","article-title":"N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC\/BHF heart protection study","volume":"49","author":"Emberson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB74|cit74","doi-asserted-by":"crossref","DOI":"10.1177\/1741826711417341","article-title":"A multiple biomarker risk score for guiding clinical decisions using a decision curve approach","author":"Hughes","year":"2012","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1373\/clinchem.2010.157842","article-title":"Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study","volume":"58","author":"Wild","year":"2012","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/hrt.2009.185751","article-title":"The 10 commandments of troponin, with special reference to high sensitivity assays","volume":"97","author":"Jaffe","year":"2011","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1161\/CIRCULATIONAHA.110.009928","article-title":"Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women\u2019s Health Study","volume":"123","author":"Everett","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1373\/clinchem.2011.179176","article-title":"Increased Cardiac Troponin I as Measured by a High-Sensitivity Assay Is associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey","volume":"58","author":"Apple","year":"2012","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB81|cit81","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2011.179226","article-title":"Troponin-Specific Autoantibody Interference in Different Cardiac Troponin I Assay Configurations","author":"Savukoski","year":"2012","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/07853890500472151","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond","volume":"38","author":"Boger","year":"2006","journal-title":"Ann Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","article-title":"Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg","volume":"28","author":"Leong","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/HJR.0b013e3283386419","article-title":"Cardiovascular risk scores in the prediction of subclinical atherosclerosis in young adults: evidence from the cardiovascular risk in a young Finns study","volume":"17","author":"Raiko","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07853890.2011.579149","article-title":"The incremental value of brachial flow-mediated dilation measurements in risk stratification for incident cardiovascular events: A systematic review","volume":"44","author":"Peters","year":"2012","journal-title":"Ann Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.110.953653","article-title":"Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.HYP.0000199605.35173.14","article-title":"Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: a community-based study","volume":"47","author":"Kullo","year":"2006","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/aje\/kwp428","article-title":"Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults","volume":"171","author":"Rodondi","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2011.06.027","article-title":"Systematic review of guidelines on peripheral artery disease screening","volume":"125","author":"Ferket","year":"2012","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1185\/030079906X148472","article-title":"Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies","volume":"22","author":"Bots","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurheartj\/ehq185","article-title":"Imaging of atherosclerosis: carotid intima-media thickness","volume":"31","author":"O\u2019Leary","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2011.02422.x","article-title":"Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison","volume":"271","author":"Peters","year":"2012","journal-title":"J Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/07853890.2010.499132","article-title":"Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia","volume":"42","author":"Dogan","year":"2010","journal-title":"Ann Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2009.11.075","article-title":"Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study","volume":"55","author":"Nambi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2005.02.088","article-title":"Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study","volume":"46","author":"Arad","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ahj.2009.08.007","article-title":"Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"158","author":"Budoff","year":"2009","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.168.12.1333","article-title":"Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"168","author":"Folsom","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0140-6736(11)60784-8","article-title":"Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study","volume":"378","author":"Blaha","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB104|cit104","volume-title":"Putting Prevention First: NHS Health Check: Vascular Risk Assessment and Management Best Practice Guidance","author":"Department of Health","year":"2009"},{"key":"10.1111\/j.1742-1241.2012.02956.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"2H","DOI":"10.1016\/j.amjcard.2006.03.002","article-title":"From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report","volume":"98","author":"Naghavi","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.02956.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2012.02956.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:03:24Z","timestamp":1643349804000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2012.02956.x"}},"subtitle":["Risk stratification markers"],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":105,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2012.02956.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}